| Inclusion criteria | Exclusion criteria | Rationale for exclusion criteria |
---|---|---|---|
Population | Symptomatic and asymptomatic patients (healthy people) | Hospitalised patients with infections >48Â h after admission | Increased risk of colonisation with drug-resistant bacteria from the hospital environment |
Hospitalised patients with a community infection (<48Â h from admission) | Patients with post-surgery infections | Â | |
 | Burn-associated infections |  | |
 | Sample of health-care workers, medical or nursing students with medical rotations |  | |
 | ICU patients referred from hospital wards or patients with central-line-associated bloodstream infections | High probability that these patients are infected with resistant bacteria | |
 | Patients with device-related infections (catheter, implants, dialysis-associated infections or ventilation-associated infections) | Devices are more prone to infection with resistant bacteria | |
 | Patients with persistent diseases (tuberculosis, H. pylori, syphilis, Pseudomonas aeruginosa, Mycobacterium leprae or Salmonella typhi) | Asymptomatic infections that remains undetected for a long duration; these require prolonged antibiotic treatments and it is considered treatment failure if the bacterium is isolated after treatment | |
 | >50% of the sample are immunocompromised patients | Infections due to opportunistic bacteria that normally do not cause infections | |
 | Patients with cystic fibrosis or bronchiectasis and cancer patients | Comorbidities that increase the risk of infection | |
Intervention | Any antibiotic exposure for any infection <14Â days (prospective or retrospective) | Long-term antibiotic treatment >2 continuous weeks | Higher probability of killing susceptible organisms and increased risk of carriage of resistant isolates |
Control/comparator | Patients without antibiotic exposure | Â | Â |
Patients with a different antibiotic exposure, dose, frequency or route of administration | If there are no before and after measurements of resistance | Â | |
Outcome | Prevalence of resistance in exposed and unexposed patients | If there are no before and after measurements of resistance | Â |
 | Duplicate isolate reporting |  | |
Time | Time between antibiotic exposure and isolation of resistant organisms | Studies were excluded if there were no data available on the last known antibiotic exposure | Â |
Setting | Primary care | Â | Â |
General practices | Â | Â | |
Outpatient clinics | Â | Â | |
Paediatric clinics | Â | Â | |
Emergency department | Â | Â |